KOSPIFood & Beverage145990

Samyang

₩40,150▲ 0.50%2026-11-18 close
Market Cap
₩414.1B
Turnover
₩500M
Volume
10K
Shares out.
10.3M
PER
—
PBR
0.2×
EPS
-₩13,738
Dividend Yield
4.19%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩1,750 per share · Prices as of the 2026-11-18 close

01

Report overview

Operating recovery, but net earnings swings remain the key test

Samyang's revenue has risen for three straight quarters through the third quarter of 2026, but a net loss attributable to controlling shareholders of KRW 313.9 billion in 2025 keeps earnings quality the central question.

  1. 1

    Third-quarter 2026 revenue was KRW 709.8 billion, up 6.6% year on year, while operating profit fell 54.2% to KRW 17.6 billion.

  2. 2

    Net income attributable to controlling shareholders was KRW 203.5 billion in the same quarter, far above operating profit, so how much non-operating income it reflects is the next item to check.

  3. 3

    The 2025 net loss attributable to controlling shareholders was KRW 313.9 billion, a swing to deficit, while operating profit stayed positive at KRW 111.7 billion.

  4. 4

    Group-level chemical sales reached KRW 2.83 trillion in 2025, or 55.48% of total group sales, ahead of the food business.

  5. 5

    Operating cash flow was KRW 204.5 billion in 2025, well above KRW 84.9 billion in 2022, indicating the core business continues to generate cash.

02

Business structure

Samyang is organized around two core businesses: food, covering sugar, flour, starch sugar and oils, and chemicals, covering ion-exchange resins, engineering plastics (EP) and PET bottle materials.

A Samyang Group profile cites domestic market shares of 32% in sugar, 28% in starch and starch sugar, and 10% in flour for the food side. On the chemical side, the same profile cites shares of 38% for ion-exchange resins, 28% for PET bottles and 16% for PCR.

These are group-level figures and may differ from Samyang's standalone sales mix. A company analysis report put food at about 50% of Samyang's own sales, while chemicals were larger on a consolidated basis.

At group level, 2025 chemical sales were KRW 2.83 trillion, or 55.48% of total group sales of KRW 5.10 trillion, compared with KRW 1.52 trillion for food.

The food business is driven by raw material prices for raw sugar, wheat and corn, along with oil prices and exchange rates, and is considered less sensitive to the broader economic cycle.

The chemical business weakened under low-priced competition from Chinese producers amid oversupply, and the group is now shifting toward specialty materials such as eco-friendly, semiconductor and personal care products.

In October 2025 the group reported plans to spin off its bio business and make chemicals and food its two main pillars. The structure reads as a food base built on sugar and flour, with higher-value chemical materials added on top.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩665.9B₩38.4B5.8%
2025Q4₩602.9B₩10.7B1.8%
2026Q1₩608.3B₩21.1B3.5%
2026Q2₩705.5B₩43.1B6.1%
2026Q3₩709.8B₩17.6B2.5%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩2.7T₩82B₩69B3.1%5.2%92.7%
2023₩2.7T₩113.2B₩106.9B4.3%7.1%87.2%
2024₩2.7T₩133.5B₩121.5B5.0%7.0%70.5%
2025₩2.6T₩111.7B-₩313.9B4.4%−19.5%103.1%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-13

04

Earnings analysis

Annual revenue was KRW 2.65 trillion in 2022, KRW 2.65 trillion in 2023 (no change year on year), KRW 2.67 trillion in 2024 (up 0.8%) and KRW 2.56 trillion in 2025 (down 4.1%). Of 2022 to 2025, 2024 was the largest year and 2025 the smallest.

Operating profit rose from KRW 82 billion in 2022 to KRW 113.2 billion in 2023 (up 38.0%) and KRW 133.5 billion in 2024 (up 18.0%), then fell to KRW 111.7 billion in 2025 (down 16.3%). The operating margin was 3.1%, 4.3%, 5.0% and 4.4% for 2022 through 2025, peaking in 2024.

Net income attributable to controlling shareholders rose to KRW 106.9 billion in 2023 (up 54.9%) and KRW 121.5 billion in 2024 (up 13.7%), but in 2025 it swung to a net loss of KRW 313.9 billion. Net loss including non-controlling interests was KRW 302.4 billion in 2025.

Because operating profit stayed positive while net results turned to a large loss, the size of non-operating or one-off items is the central question. The debt ratio rose to 103.1% at the end of 2025 from 70.5% in 2024, and controlling shareholders' equity was KRW 1.61 trillion of total equity of KRW 1.79 trillion.

Quarterly, revenue was KRW 665.9 billion in the third quarter of 2025 with operating profit of KRW 38.4 billion and controlling net income of KRW 27.9 billion.

In the fourth quarter of 2025, revenue fell 9.5% quarter on quarter to KRW 602.9 billion, operating profit fell 72.2% to KRW 10.7 billion, and the net loss attributable to controlling shareholders reached KRW 403.9 billion.

In the first quarter of 2026, revenue was KRW 608.3 billion, operating profit rose 97.0% to KRW 21.1 billion, and controlling net income of KRW 30.9 billion returned to profit. Second-quarter 2026 operating profit of KRW 43.1 billion was the highest of the last five quarters on the disclosed record.

Third-quarter 2026 revenue of KRW 709.8 billion extended growth for three straight quarters, but operating profit of KRW 17.6 billion fell 59.1% quarter on quarter and 54.2% year on year.

The four quarters from the fourth quarter of 2025 through the third quarter of 2026 add up to a controlling net loss of KRW 137.9 billion.

05

Industry analysis

The food business is tied to raw material prices and exchange rates. Group-level figures show the food segment's share of sales rising from 35.5% to 46.6% during a period of raw material inflation after 2021. In domestic sugar and starch, Samyang competes with CJ Cheiljedang and Daesang, among others.

When raw material prices fall, the ability to pass on price changes narrows, so margins depend on purchase timing and the pace of pricing adjustments.

The chemical business faced margin pressure in commodity products after COVID-19, as low-priced competition from Chinese producers with excess capacity weighed on the sector. The group's chemical share of sales rose from 43.6% in 2023 and 48.3% in 2024 to 49.5% in the first half of 2025.

That shift coincides with a rising mix of high-function products such as engineering plastics and ion-exchange resins. Group materials cite a 38% domestic share for ion-exchange resins. Growth in semiconductor process materials, handled by group affiliate Samyang NC Chem, is also cited.

Across the cycle, food earnings are sensitive to raw material swings, while chemical earnings depend on whether Chinese oversupply eases. Against peers, leading domestic positions in sugar and ion-exchange resins are a strength, while a large share of commodity petrochemical products is a weakness.

06

Outlook

The outlook can be split into two questions. The first is whether quarterly revenue growth is converting into operating profit. The second is whether the non-operating losses that weighed on net results recur.

Second-quarter 2026 operating profit of KRW 43.1 billion was the quarterly high, and third-quarter operating profit fell to KRW 17.6 billion, so the recovery in operating profit has not been continuous.

The group has announced a spin-off of its bio business and a strengthened independent structure around chemicals and food as two core pillars. Expanding the share of specialty products is presented as the route to better chemical profitability.

Food margins will depend on raw material and exchange-rate trends and on pricing in the domestic sugar market. The source of the KRW 203.5 billion net income attributable to controlling shareholders in the third quarter of 2026 can be confirmed in the notes to the quarterly report.

The nature of the KRW 403.9 billion controlling net loss in the fourth quarter of 2025, including whether it was one-off, should be checked in the annual report. The debt ratio rose to 103.1% at the end of 2025, so changes in borrowing structure and interest burden are variables for the outlook.

Whether capital is strengthened against controlling shareholders' equity of KRW 1.61 trillion is also worth tracking. Whether the dividend policy holds through loss-making periods will be confirmed through the board resolution in the annual report.

The operating margin and the composition of net results in the next annual report are therefore the next checkpoints for the company.

07

Valuation

PER
—
PBR
0.2×
ROE
-7.1%
EPS
-₩13,738
BPS
₩192,019
Dividend per share
₩1,750

The share price is trading at a low level relative to book net assets, with the price-to-book ratio well below 1x. By contrast, net losses over the last four quarters mean the price-to-earnings ratio cannot be calculated.

Because earnings-based multiples are hard to compare, the market often looks at net assets alongside operating cash flow. Operating cash flow was KRW 263.3 billion in 2023, KRW 253.9 billion in 2024 and KRW 204.5 billion in 2025, staying above KRW 200 billion for three straight years.

The debt ratio rose from 70.5% in 2024 to 103.1% in 2025, which adds to the debt burden against equity and is weighed as a discount factor in asset-based valuation.

Shareholder return views depend on whether dividends continue after the swing to loss, so the board resolution in the annual report should be read together with the valuation.

Against the company's historical PER band, the current period is one where earnings-based multiples cannot be calculated, which shifts weight toward asset-based measures.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-13

08

Bull factors

Quarterly revenue up for three straight quarters

Revenue rose from KRW 608.3 billion in the first quarter of 2026 to KRW 705.5 billion in the second and KRW 709.8 billion in the third, three straight quarters of growth. Third-quarter revenue was up 6.6% year on year.

Second-quarter operating profit of KRW 43.1 billion was the highest of the last five quarters on the disclosed record, and it followed the return to net profit in the first quarter.

Rising chemical mix and specialty shift

Group-level chemical share of sales rose from 43.6% in 2023 and 48.3% in 2024 to 49.5% in the first half of 2025. Press reports also described a large increase in chemicals' share of profit over the same period.

The group is moving its portfolio toward high-value products such as engineering plastics and ion-exchange resins, and materials for semiconductors and personal care.

Low price relative to book value and steady cash generation

The price-to-book ratio is well below 1x, so the price is modest relative to net assets. Operating cash flow exceeded KRW 200 billion in each of the three years, though 2025 was lower than 2023. If dividends hold, there is room for shareholder returns, though continuity is a matter for the annual report.

09

Bear factors

Controlling net loss and gap with operating profit

The 2025 net loss attributable to controlling shareholders was KRW 313.9 billion, and the net loss including non-controlling interests was KRW 302.4 billion. The fourth-quarter 2025 controlling net loss of KRW 403.9 billion was far larger than that quarter's operating profit of KRW 10.7 billion.

Third-quarter 2026 net income of KRW 203.5 billion also exceeded operating profit, so whether these items are one-off determines how durable the profit is read to be.

Declining operating profit

Operating profit fell 16.3% to KRW 111.7 billion in 2025, and the operating margin dropped to 4.4%. Third-quarter 2026 operating profit of KRW 17.6 billion was down 54.2% year on year, so revenue growth has not translated into higher profit. The debt ratio at the end of 2025 was 103.1%, up from 70.5% in 2024, which narrows financial room.

Chemical cycle and food raw material swings

The chemical business has faced margin pressure in commodity products as low-priced competition from Chinese producers and oversupply persist. In food, swings in raw sugar and wheat prices and exchange rates can move margins. A larger chemical share at group level also means greater exposure to the chemical cycle.

10

Risk factors

Raw materials and FX

The food business is exposed to raw sugar, wheat and corn prices, oil prices and exchange rates. When raw material costs rise and price pass-through lags, margins compress, and when they fall, price cut pressure can emerge. Procurement timing and the pace of pricing adjustments drive how much quarterly earnings move.

Chemical cycle and Chinese oversupply

The chemical business is exposed to low-priced competition from Chinese producers during periods of oversupply. Where commodity products make up a large share, prices can fall quickly and erode earnings.

Raising the share of high-function products is presented as a way to reduce this risk, but the speed of that shift is an open variable.

Balance sheet and group restructuring

The debt ratio rose to 103.1% at the end of 2025, and continued controlling net losses could heighten concern about erosion of equity. The group is changing its structure, including the spin-off of its bio business, so the effect of governance changes on operations also needs watching. Debt repayment and capital plans are the key items to track for this risk.

11

What to watch next

  1. February 2027 (typical timing)

    The 2026 full-year preliminary results will show whether the gap between operating profit and controlling net income narrowed after the large fourth-quarter 2025 net loss.

  2. By March 31, 2027

    This is the filing deadline for the 2026 annual report, which will confirm the full-year operating margin, debt ratio, net results including non-controlling interests, and dividend decisions.

  3. By May 15, 2027

    This is the filing deadline for the first-quarter 2027 report, which will show whether operating profit recovery continued after the fourth quarter of 2026 and how much non-operating income is reflected.

12

Overall view

Samyang combines food and chemical businesses, and its 2025 annual revenue of KRW 2.56 trillion was the smallest year of 2022 through 2025.

Operating profit peaked at KRW 133.5 billion in 2024 and fell to KRW 111.7 billion in 2025, while net income attributable to controlling shareholders swung to a net loss of KRW 313.9 billion.

Quarterly revenue rose for three straight quarters through 2026, and controlling net income returned to profit from the first quarter, but third-quarter operating profit of KRW 17.6 billion was below the prior-year quarter.

Controlling net losses over the last four quarters total KRW 137.9 billion, so the gap between operating profit and net results is central to reading earnings.

The group's shift toward chemicals and specialty products is presented as a structural direction, while chemical cycles and food raw material swings remain sources of earnings volatility.

On valuation, the price-to-book ratio is well below 1x, while the price-to-earnings ratio cannot be calculated because of the loss period. The next checkpoints are the 2026 full-year preliminary results, the 2026 annual report due by March 31, 2027, and the first-quarter 2027 report due by May 15, 2027.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. newsclaim.co.kr
  2. lawissue.co.kr
  3. thefairnews.co.kr
  4. vegannews.co.kr
  5. biztribune.co.kr
  6. onews.tv
  7. digitaltoday.co.kr
  8. moneytoring.ai
  9. newstong.co.kr
  10. ngonews.kr
  11. m.samyangspecialty.com
  12. kmib.co.kr
  13. newsway.co.kr
  14. newstomato.com
  15. kmib.co.kr
  16. fnnews.com
  17. thevaluenews.co.kr
  18. jobkorea.co.kr

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis